Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Dec 14, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Siemens Healthineers said today that it will invest $300 million to expand and upgrade its 500,000-sq. ft. laboratory diagnostics manufacturing and R&D facility in Walpole, Massachusetts, over the next four years.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Apr
06
Featured Webinar

Reducing COVID-19 Infections Rates at a University Campus with Mass Screening

Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.

Apr
16
Featured Webinar

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

What's Popular?

In Infectious Disease

  1. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  2. German Stores to Begin Selling COVID-19 Rapid Antigen Tests for Home Use

  3. FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

  4. Ortho Clinical Diagnostics Nabs CE Mark for Semi-Quantitative SARS-CoV-2 Antibody Tests

  5. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.